Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Wojcechowskyj

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Systems|August 6, 2018
Quantitative Yeast Genetic Interaction Profiling of Bacterial Effector Proteins Uncovers a Role for the Human Retromer in Salmonella InfectionKristin L Patrick, Jason A Wojcechowskyj, Samantha L Bell, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Cell Reports|May 12, 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteinsJoseph Hiatt, Devin A Cavero, Michael J McGregor, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Systems|August 6, 2018
Quantitative Yeast Genetic Interaction Profiling of Bacterial Effector Proteins Uncovers a Role for the Human Retromer in Salmonella InfectionKristin L Patrick, Jason A Wojcechowskyj, Samantha L Bell, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Cell Reports|May 12, 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteinsJoseph Hiatt, Devin A Cavero, Michael J McGregor, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 2